Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Addus HomeCare Price Performance
ADUS opened at $93.91 on Thursday. Addus HomeCare has a twelve month low of $68.57 and a twelve month high of $108.11. The firm has a market cap of $1.51 billion, a price-to-earnings ratio of 34.03, a PEG ratio of 2.48 and a beta of 0.85. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.33. The company has a fifty day simple moving average of $86.82 and a 200 day simple moving average of $83.58.
Addus HomeCare (NASDAQ:ADUS - Get Rating) last announced its earnings results on Monday, August 1st. The company reported $0.91 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.01). Addus HomeCare had a net margin of 4.90% and a return on equity of 8.63%. The business had revenue of $236.94 million for the quarter, compared to analyst estimates of $238.40 million. During the same quarter in the prior year, the business earned $0.78 earnings per share. The firm's revenue was up 8.7% on a year-over-year basis. Equities research analysts expect that Addus HomeCare will post 3.18 EPS for the current fiscal year.
Wall Street Analyst Weigh In
ADUS has been the subject of a number of research reports. Stifel Nicolaus assumed coverage on Addus HomeCare in a report on Tuesday, June 28th. They set a "buy" rating and a $101.00 target price for the company. Stephens decreased their price objective on shares of Addus HomeCare from $110.00 to $101.00 and set an "overweight" rating for the company in a research note on Tuesday, June 21st. Oppenheimer cut their target price on shares of Addus HomeCare from $135.00 to $130.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 3rd. Royal Bank of Canada decreased their price target on shares of Addus HomeCare from $111.00 to $110.00 and set an "outperform" rating for the company in a research report on Wednesday, August 3rd. Finally, Bank of America began coverage on Addus HomeCare in a research report on Wednesday, April 13th. They issued a "buy" rating and a $110.00 price objective on the stock. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, Addus HomeCare currently has a consensus rating of "Buy" and an average price target of $110.40.
Insider Buying and Selling at Addus HomeCare
In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 1,718 shares of the company's stock in a transaction that occurred on Tuesday, May 24th. The stock was sold at an average price of $85.00, for a total value of $146,030.00. Following the transaction, the executive vice president now directly owns 7,012 shares of the company's stock, valued at approximately $596,020. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 1,718 shares of the stock in a transaction on Tuesday, May 24th. The shares were sold at an average price of $85.00, for a total transaction of $146,030.00. Following the transaction, the executive vice president now directly owns 7,012 shares in the company, valued at approximately $596,020. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP David W. Tucker sold 2,080 shares of the business's stock in a transaction dated Friday, July 15th. The stock was sold at an average price of $90.00, for a total transaction of $187,200.00. Following the completion of the sale, the executive vice president now directly owns 8,468 shares of the company's stock, valued at approximately $762,120. The disclosure for this sale can be found here. Insiders sold a total of 26,116 shares of company stock worth $2,433,550 in the last 90 days. 4.50% of the stock is owned by corporate insiders.
